George Medicines, a UK biopharma focused on cardiometabolic diseases, has entered into an exclusive licensing and supply ...

NodThera, a privately-held biotech working in chronic inflammatory diseases through selective modulation of the NLRP3 ...

The European Commission has granted marketing authorization in the European Union (EU) for German pharma major Bayer’s Nubeqa ...

US biotech major Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing ...

South Korea’s biosimilar drug developer Samsung Bioepis today released its Third Quarter 2025 Market Report, marking the ...

The US Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu ...

Positive high-level results have been presented from the final overall survival (OS) analysis of the FLAURA2 Phase III trial.

Swiss pharma giant Roche today reported mixed results from late-stage trials for its experimental drug astegolimab, which is ...

Sweden’s OncoZenge has chosen Meribel Pharma Solutions—formerly Recipharm—to be the contract development and manufacturing ...

The Dutch Ministry of Economic Affairs (EZ) has presented an ambitious action plan to increase public and private investment ...

Denmark-based allergy immunotherapy specialist ALK Abello today announced that the UK’s National Institute for Health and ...

Indian pharma major Sun Pharma (BSE: 524715) reported positive top-line results from two late-stage studies of its psoriasis ...